Pfizer CEO Albert Bourla admitted that his company manufactured SARS-CoV-2 in their labs for the development of mRNA vaccines rather than use a naturally-occurring coronavirus.
Bourla made the comments during a CNBC interview in December 2021 while explaining how Pfizer is reformulating an mRNA vaccine specifically to treat the mild Omicron variant of COVID.
“The data that we received are data that they got from what we call a pseudovirus, so it’s not the real virus, it is a virus that we have constructed in our labs and it is identical with the Omicron virus,” Bourla said.
A “pseudovirus” as Bourla described is a recombinant viral particle that’s been scientifically manipulated from several different viruses to make a more pathogenic virus.
Read More: Pfizer CEO Admits COVID-19 Created in Lab
